Physician profile
Corina Serer
NPI 1700875556
$2,772.84
in general payments reported to CMS, 2019-2025
15 companies · $726 in 2025
The $726 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.24 · 2021: $536 · 2022: $616 · 2023: $288 · 2024: $508 · 2025: $726.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,520.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,550.13 | 2021-2025 | Rinvoq, Skyrizi |
| Pfizer INC. | $463.52 | 2023-2025 | |
| Celgene Corporation | $208.98 | 2022-2024 | Zeposia |
| Merck Sharp & Dohme LLC | $99.24 | 2019 | |
| Ardelyx, INC. | $97.96 | 2022-2023 | Ibsrela |
| Genzyme Corporation | $71.78 | 2024-2025 | |
| Gilead Sciences, INC. | $71.11 | 2021-2025 | |
| Ipsen Biopharmaceuticals, INC | $46.49 | 2025 | Iqirvo |
| Intra-Sana Laboratories | $41.57 | 2021-2022 | |
| Novo Nordisk INC | $36.55 | 2025 | Wegovy |
| Nestle Healthcare Nutrition INC. | $22.53 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.86 | 2024 | Entyvio |
| Janssen Biotech, INC. | $15.49 | 2022 | |
| Medtronic, INC. | $15.28 | 2023 | Gi Genius |
| Janssen Pharmaceuticals, INC | $13.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corina Serer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.